Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Prepaid Assets (2020 - 2025)

Pulse Biosciences has reported Prepaid Assets over the past 6 years, most recently at $1.9 million for Q3 2025.

  • Quarterly results put Prepaid Assets at $1.9 million for Q3 2025, up 35.48% from a year ago — trailing twelve months through Sep 2025 was $1.9 million (up 35.48% YoY), and the annual figure for FY2024 was $1.4 million, up 46.52%.
  • Prepaid Assets for Q3 2025 was $1.9 million at Pulse Biosciences, up from $1.8 million in the prior quarter.
  • Over the last five years, Prepaid Assets for PLSE hit a ceiling of $3.3 million in Q2 2021 and a floor of $849000.0 in Q1 2023.
  • Median Prepaid Assets over the past 5 years was $1.2 million (2023), compared with a mean of $1.5 million.
  • Biggest five-year swings in Prepaid Assets: surged 283.16% in 2021 and later plummeted 67.49% in 2022.
  • Pulse Biosciences' Prepaid Assets stood at $963000.0 in 2021, then increased by 4.67% to $1.0 million in 2022, then decreased by 4.46% to $963000.0 in 2023, then soared by 46.52% to $1.4 million in 2024, then soared by 32.6% to $1.9 million in 2025.
  • The last three reported values for Prepaid Assets were $1.9 million (Q3 2025), $1.8 million (Q2 2025), and $1.6 million (Q1 2025) per Business Quant data.